by editor | Mar 12, 2013 | Clinicians, Participants, Researchers
Highlights the need for a clinical trial says Oncologist Medical Oncologist Dr Andrew Haydon, who works on cancer aspects of ASPREE, said that a recent association between aspirin and a reduced risk of developing melanoma, was a call for closer investigation of...
by editor | Feb 22, 2013 | Clinicians, Participants
John McNeil discusses publicity of aspirin studies with the Australian Ageing Agenda ASPREE Principal Investigator, Professor John McNeil spoke to the Australian Ageing Agenda about the ASPREE study and the mixed messages about aspirin in the media....
by editor | Jan 31, 2013 | Clinicians, Participants
ASPREE and leading AMD researcher pens open letter to participants Dear ASPREE participants and interested parties, Recently you may have heard press reports that suggested aspirin might worsen an infrequent type of the eye disease called age – related macular...
by editor | Jan 23, 2013 | Clinicians, Participants, Researchers
Authors of aspirin and AMD paper say study lacks robustness to change clinical practice ANNOUNCEMENT Melbourne, January 23 2013 – Professor John McNeil, Head of Monash University’s Department of Epidemiology and Preventive Medicine and Lead Investigator of the...
by editor | Oct 30, 2012 | Clinicians, Participants, Researchers
Aspirin may block the growth of colorectal tumours with a specific genetic mutation Researchers affiliated with the Harvard Medical School reported that aspirin was associated with a prolonged life of patients with tumours that carried the mutated PIK3CA gene –...
Recent Comments